WednesdayMay 02, 2018 2:03 pm

The Green Organic Dutchman Ltd. (TSX: TGOD) Lists on the TSX Today

Shares of The Green Organic Dutchman commenced trading on the Toronto Stock Exchange today under the symbol “TGOD” TGOD has raised approximately $270 million in private placements with over 5,000 shareholders, including a $55 million strategic investment from established marijuana industry leader Aurora Cannabis TGOD has a funded capacity of 116,000 kg of premium organic cannabis Canada slated to legalize adult use recreational cannabis in mid-2018 The Green Organic Dutchman Ltd. (TSX: TGOD) has successfully raised more than $270 million in private placements with over 5,000 shareholders. Through these efforts, TGOD is establishing one of the largest organic cannabis companies…

Continue Reading

TuesdayMay 01, 2018 12:51 pm

Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P) Developing Portfolio of Cannabis Companies

Portfolio now covers cannabis production, distribution and new market research Two subsidiaries are late-stage applicants for cannabis licensing Partnerships include unique research into efficacy of CBD for pain management in canine osteoarthritis Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P) is putting together a portfolio of strategically positioned cannabis companies to create a vertically integrated seed-to-sale organization addressing all aspects of the burgeoning cannabis market. The company invests in cannabis-related businesses that fill a needed role in its vertical integration plan, offering its expertise, such as management, HR and marketing, to help them develop and complement overall goal.…

Continue Reading

MondayApr 30, 2018 11:03 am

Global Hemp Group, Inc. (CSE: GHG) (FRA: GHG) (OTC: GBHPF) Set to Gain from Hemp Legalization Drive in U.S.

2018 Farm Bill promotes federal legalization of non-psychoactive industrial hemp in United States Majority of states already have legal pilot programs to analyze industrial hemp’s potential for boosting agriculture Global Hemp Group already testing revitalized cultivation of hemp in Canada, with interest in U.S. market While states continue to grapple with how they will approach medical and recreational marijuana controversies, as well as the federal government’s drug classification policy in the United States, a more cooperative camaraderie appears to be developing nationwide in regard to the growth of industrial hemp, the cannabis plant’s non-psychoactive breed. The U.S. Senate is debating…

Continue Reading

ThursdayApr 26, 2018 1:43 pm

Global Hemp Group, Inc. (CSE: GHG) (FRA: GHG) (OTC: GBHPF) Building Portfolio on Promise of Revitalized Hemp Industry

Canada on-track to legalize cannabis plant derivatives for all potential uses this year U.S. Senate set to debate update to 2014 Farm Bill using research showing hemp’s agricultural promise Global Hemp Group pioneering new commercial-scale cultivation of hemp in New Brunswick As pending legislation authorizing the cultivation of hemp without drug enforcement oversight opens the potential for U.S. federal government friendliness toward cannabis production, Global Hemp Group, Inc. (CSE: GHG) (FRANKFURT: GHG) (OTC: GBHPF) is busy pledging its visionary portfolio to the market for consumer goods arising from the cannabis species’ non-psychoactive varieties. Global Hemp Group joined other players in…

Continue Reading

TuesdayApr 24, 2018 12:21 pm

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Begins Human Clinical Study of Its High Absorption TurboCBD Capsules

Study will measure the cardiovascular and cognitive health effects of patented DehydraTECH, its disruptive delivery technology Data generated will help company’s development of next-generation cannabinoid product formulations Chris Bunka, CEO, and John Docherty, president, to present at the ‘Next Generation Nicotine Delivery USA 2018’ conference in Atlanta on April 24 and 25 Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) has started a human clinical study in Europe on the health effects of its high absorption TurboCBD™ capsules. LXRP, a drug delivery platform innovator, will be conducting the study to evaluate the cardiovascular and cognitive health effects of its patented DehydraTECH™…

Continue Reading

MondayApr 23, 2018 11:52 am

Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF) Scores Slam Dunk with Grow Facilities in Two Largest Cannabis Markets

North American medical marijuana market estimated at $9-10 billion Over one million square feet of cannabis greenhouse space planned Signed take or pay supply agreement with world’s largest pure play cannabis company Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF) seems destined for a future as bright as its name. According to a recent article, titled ‘Who will Dominate California -- the World’s Largest Cannabis Market?’ (http://cnw.fm/Lc8w7), "Sunniva’s once-in-a-lifetime opportunity to become one of California’s dominant cannabis companies cannot be over-emphasized." The vertically integrated medical cannabis producer is constructing purpose built, large-scale current good manufacturing practices (cGMP) compliant greenhouse facilities in North…

Continue Reading

FridayApr 20, 2018 12:46 pm

TransCanna™ is “One to Watch”

Creating a distribution network throughout California to serve the state’s $8.6 billion cannabis industry Plans include construction of 10,000 square foot distribution and transportation facility in Adelanto, California, with plans for several more in strategic locations around the state Holds transportation and distribution permit from Adelanto municipal government Has access to Track & Trace software platform, a requirement of California’s Bureau of Cannabis Control TransCanna™ specializes in assisting clients who are cannabis farmers and manufacturers get recognized by end consumers who in turn purchase their products. TransCanna™ offers services to support every aspect of the cannabis-related eco-system; from branding and design, to…

Continue Reading

FridayApr 20, 2018 12:02 pm

Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF) Receives Temporary License to Break Ground on Cannabis Cultivation Facility in California

Permanent, annual state license for this facility to be applied for within the next 120 days Production capacity projected to reach over 100,000 kg of medical cannabis per year Californian facility will provide tenancy for other licensed cannabis cultivators On April 12, 2018, Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF) announced that its subsidiaries in the United States have received the necessary temporary licenses from the State of California to proceed with the construction of the company’s cultivation facilities in Cathedral City, California (http://cnw.fm/b4YDt). Licenses are temporary while the state develops permanent regulations for its newly legalized cannabis industry. Sunniva will apply…

Continue Reading

ThursdayApr 19, 2018 11:12 am

Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF) is “One to Watch”

Uniquely positioned in the largest legalized medical and recreational cannabis markets – California and Canada Construction underway for a modern, agri-technology greenhouse facility in California capable of producing over 100,000 kg of premium medical cannabis annually, once phase 1 and 2 are complete Received all required California temporary licenses to cultivate, process cannabis; will apply for annual state licenses within next four months Designs completed for purpose-built current Good Manufacturing Practice (cGMP) compliant greenhouse facilities in British Columbia capable of producing 100,000 kg of premium medical cannabis per year and over 25,000 kg of trim used for extraction Application for…

Continue Reading

WednesdayApr 18, 2018 11:29 am

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Announces Significant Breakthrough with Alternative Nicotine Delivery Technology

Delivery technology already proven effective in cannabinoid delivery, now being studied in nicotine absorption Positive topline results on completion of first ingestible nicotine in vivo (animal) absorption study LXRP’s long-term strategy is to partner with leading firms in the tobacco industry, providing an additional layer of effectiveness in products to their already established consumer base Potential to revolutionize smokeless tobacco and the tobacco industry The drug delivery platform innovator Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) has announced a significant breakthrough in alternative nicotine delivery technology. This cannabis-focused food bioscience company has a proprietary technology for improved delivery of bioactive…

Continue Reading

CanadianCannabisWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000